SRW Cel System for Aging

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Regenerative Wellness Center, Salt Lake City, UT
Aging
SRW Cel System - DietarySupplement
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

SRW Laboratories has formulated the Cel System protocol, a group of three formulas designed to interact with each of the 9 Hallmarks of Aging and combined this with an App that supports positive lifestyle changes, with a view that, if we can positively impact each Hallmark, we can support healthy aging.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Change in epigenetic age from baseline to 12 months

Month 12
Biological age
Month 12
C-reactive protein
Inflammatory marker IL-6

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

1 Treatment Group

SRW Cel system
1 of 1
Experimental Treatment

50 Total Participants · 1 Treatment Group

Primary Treatment: SRW Cel System · No Placebo Group · Phase 2

SRW Cel system
DietarySupplement
Experimental Group · 1 Intervention: SRW Cel System · Intervention Types: DietarySupplement

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change in epigenetic age from baseline to 12 months
Closest Location: Regenerative Wellness Center · Salt Lake City, UT
Photo of Salt Lake City  1Photo of Salt Lake City  2Photo of Salt Lake City  3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Aging
0 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are female and post-menopausal.
You are willing and able to consume study supplements throughout the duration of study period.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References